Bioprocess Automation Global Market Opportunities And Strategies To 2034
상품코드:1895259
리서치사:The Business Research Company
발행일:2025년 12월
페이지 정보:영문 353 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 바이오프로세스 자동화 시장은 2024년에 약 56억 7,239만 달러 규모에 달하며, 2019년 이후 13.37%의 CAGR로 성장하고 있습니다. 이 시장은 2024년 56억 7,239만 달러에서 2029년에는 102억 3,774만 달러로, 12.53%의 성장률로 확대할 것으로 예측됩니다. 향후 2029년 이후에도 CAGR 12.02%로 계속 성장하며 2034년에는 180억 5,934만 달러에 달할 전망입니다.
바이오프로세스 자동화는 첨단 제어 시스템, 센서, 로봇 기술, 소프트웨어를 활용하여 생물학적 제조 공정을 모니터링, 관리, 최적화하는 것을 말합니다. 이러한 공정에는 세포배양, 발효, 정제, 제형화, 바이오의약품, 백신 및 기타 생명공학 제품 생산에 있으며, 세포배양, 발효, 정제, 제형화 등이 포함됩니다. 바이오프로세스 자동화의 주요 목적은 공정 효율성, 일관성, 제품 품질을 향상시키는 동시에 인적 오류와 운영 비용을 줄이는 데 있습니다.
맞춤형 의료에 대한 수요 증가
지난 기간 중 바이오프로세스 자동화 시장은 주로 맞춤형 의료에 대한 수요 증가에 의해 주도되어 왔습니다. 이러한 수요는 신속한 전환, 정밀한 공정 제어, 소규모 생산의 확장성을 지원할 수 있는 자동화 기술에 대한 강력한 원동력이 되었습니다. 자동화 플랫폼을 통해 제조업체는 고도로 전문화된 치료법의 변동성을 줄이고 일관성을 확보할 수 있으며, 바이오프로세스 자동화를 보다 광범위하게 도입할 수 있는 기반을 마련할 수 있게 되었습니다. 예를 들어 미국 비영리단체인 Personalized Medicine Coalition에 따르면 2024년 2월 FDA는 역대 최다인 20개의 새로운 개인맞춤형 의약품을 승인했으며, 이는 신규 치료용 분자 실체의 38%를 차지하며, 개인맞춤형 치료제가 신약 승인 건수의 3분의 1을 차지할 것으로 예상했습니다. 승인 건수의 3분의 1 이상을 차지하는 것은 4년 연속으로 달성한 것으로 나타났습니다. 특히 희귀질환 분야에서 두드러진 증가세를 보였으며, 16건의 맞춤의료가 승인되었습니다. 이는 2022년 6건에 불과했던 것에 비해 2배 이상 증가한 수치로, 그동안 미해결된 희귀하고 생명을 위협하는 유전성 질환의 미충족 의료 수요에 대한 대응이 비약적으로 진전되었음을 반영합니다. 따라서 바이오프로세스 자동화 시장의 성장은 주로 맞춤형 의료에 대한 수요 증가에 의해 주도되었습니다.
바이오프로세스 제어에서 인공지능(AI)과 머신러닝(ML) 통합의 진전
바이오프로세스 자동화 시장에서 사업을 운영하는 기업은 예측 모델링, 실시간 의사결정, 업스트림 및 다운스트림 공정의 적응형 피드백 제어를 실현하기 위해 인공지능(AI)과 머신러닝(ML)을 바이오프로세스 제어 시스템에 통합하는 데 초점을 맞추었습니다. 이러한 혁신 기술은 규제 준수와 제품 품질을 유지하면서 수율 안정성 향상, 배치 실패 감소, 수동 개입 최소화, 시장 출시 시간 단축을 목표로 하고 있습니다. 예를 들어 2025년 7월 영국에 위치한 기술 및 혁신 센터인 CPI(The Centre for Process Innovation)는 캐나다와 영국의 공동 프로젝트인 'BALANCE(실험 학습 및 적응형 네트워크 제어를 위한 바이오리액터 자동화)'에 참여했습니다. 참여하게 되었습니다. 이 프로젝트는 니코야의 실시간 센싱, 랩맨의 자동화, 베이스투의 AI(인공지능)와 디지털 트윈, CPI의 바이오리액터 기술을 통합하여 바이오의약품 제조를 위한 AI 최적화 바이오리액터 제어 실증 플랫폼을 제공합니다. Nicoya사는 캐나다의 바이오센서 전문기업으로 특히 Alto SPR 바이오센서로 유명합니다. Labman Automation은 영국에 본사를 둔 자동화 및 로봇 개발 기업이며, Basetwo는 인공지능과 디지털 트윈 플랫폼에 주력하는 캐나다의 기술 기업입니다.
세계 바이오프로세스 자동화 시장은 다수의 소규모 기업이 진입하는 비교적 분산된 구조로 이루어져 있습니다. 2024년 기준, 시장 주요 10개사의 점유율은 전체의 19.55%를 차지하고 있습니다.
목차
제1장 개요
바이오프로세스 자동화 : 시장의 매력과 거시경제 환경
제2장 목차
제3장 표 리스트
제4장 도표 리스트
제5장 리포트 구성
제6장 시장의 특징
일반적인 시장의 정의
개요
바이오프로세스 자동화 시장 정의와 세분화
시장 세분화 : 프로세스 제어 시스템의 컴포넌트별
센서
액추에이터
컨트롤러
시장 세분화 : 조업 규모별
전임상 오퍼레이션
임상 운영
상업 생산
시장 세분화 : 운전 모드별
배치
연속 배양
연속 배양
시장 세분화 : 바이오프로세스 시스템과의 호환성별
일회용 시스템
스테인리스강
기타 바이오프로세스 시스템
제7장 주요 시장 동향
바이오프로세스 제어에서 인공지능과 기계학습의 통합 진전
AI 구동형 멀티채널 바이오센싱에 의한 실시간 바이오프로세스 감시·최적화의 변혁
지능형 세포 처리 시스템에 의한 생산 품질과 안전성의 향상
차세대 바이오프로세스 개발 시스템에 의한 프로세스 제어의 최적화
복잡한 바이오프로세스 관리에서 분산 제어 시스템(DCS)의 활용 확대
제8장 세계의 바이오프로세스 자동화 성장 분석 및 전략 분석 프레임워크
세계의 바이오프로세스 자동화 PESTEL 분석
최종사용자 산업별 분석(B2B)
제약 기업
바이오테크놀러지 기업
수탁제조 기관(CMO)
학술연구기관
기타 최종사용자
세계의 바이오프로세스 자동화 시장 : 성장률 분석
시장 성장 실적, 2019-2024
시장 성장 촉진요인 2019-2024
시장 성장 억제요인 2019-2024
시장 성장 예측, 2024-2029, 2034F
예측 성장요인/촉진요인
정량적 성장요인
촉진요인
억제요인
세계의 바이오프로세스 자동화 : TAM(Total Addressable Market)
제9장 세계의 바이오프로세스 자동화 시장 : 세분화
세계의 바이오프로세스 자동화 시장 : 프로세스 제어 시스템의 컴포넌트별, 실적과 예측, 2019-2024, 2029F, 2034F
세계의 바이오프로세스 자동화 시장 : 운영 규모별, 실적과 예측, 2019-2024, 2029F, 2034F
세계의 바이오프로세스 자동화 시장 : 운영 모드별, 실적과 예측, 2019-2024, 2029F, 2034F
세계의 바이오프로세스 자동화 시장 : 바이오프로세스 시스템과의 호환성별, 실적과 예측, 2019-2024, 2029F, 2034F
세계의 바이오프로세스 자동화 시장 : 서브 세분화, 센서, 프로세스 제어 시스템의 컴포넌트별, 실적과 예측, 2019-2024, 2029F, 2034F
세계의 바이오프로세스 자동화 시장 : 서브 세분화, 액추에이터, 프로세스 제어 시스템의 컴포넌트별, 실적과 예측, 2019-2024, 2029F, 2034F
세계의 바이오프로세스 자동화 시장 : 서브 세분화, 컨트롤러, 프로세스 제어 시스템의 컴포넌트별, 실적과 예측, 2019-2024, 2029F, 2034F
제10장 바이오프로세스 자동화 시장 : 지역·국가별 분석
세계의 바이오프로세스 자동화 시장 : 지역별, 실적과 예측, 2019-2024, 2029F, 2034F
세계의 바이오프로세스 자동화 시장 : 국가별, 실적과 예측, 2019-2024, 2029F, 2034F
제11장 아시아태평양 시장
제12장 서유럽 시장
제13장 동유럽 시장
제14장 북미 시장
제15장 남미 시장
제16장 중동 시장
제17장 아프리카 시장
제18장 경쟁 구도와 기업 개요
기업 개요
Thermo Fisher Scientific Inc
Danaher Corporation(Cytiva)
Sartorius AG
Lonza Group AG
Merck KGaA(MilliporeSigma)
제19장 기타 대기업과 혁신적 기업
F. Hoffmann-La Roche Ltd.
Siemens AG
Rockwell Automation Inc.
Emerson Electric Co.
Waters Corporation
Agilent Technologies Inc.
Eppendorf AG
Tecan Group Ltd.
Corning Inc.
Yokogawa Electric Corp.
Schneider Electric SE
Parker Hannifin Corporation
Global Biotechnology Company(CSL Behring)
Repligen Corporation
SKAN
제20장 경쟁 벤치마킹
제21장 경쟁 대시보드
제22장 주요 합병과 인수
Repligen Corporation Acquired Bioprocess Analytics Desktop Portfolio Of 908 Devices
Danaher Corporation Merging Cytiva And Pall
Beckman Coulter Life Sciences Acquired Valitacell
제23장 바이오프로세스 자동화 최근 동향
클라우드 통합형 바이오리액터에 의한 바이오의약품 개발의 추진
자동화 세포치료 제조용 Clinimacs Prodigy 플랫폼의 발매
제24장 기회와 전략
세계의 바이오프로세스 자동화 시장 2029 : 새로운 기회를 제공하는 국가
세계의 바이오프로세스 자동화 시장 2029 : 새로운 기회를 제공하는 부문
세계의 바이오프로세스 자동화 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제25장 바이오프로세스 자동화 시장 : 결론과 제안
결론
제안
제품
장소
가격
프로모션
사람들
제26장 부록
KSA
영문 목차
영문목차
Bioprocess automation refers to the use of advanced control systems, sensors, robotics and software to monitor, manage and optimize biological manufacturing processes. These processes include cell culture, fermentation, purification and formulation in the production of biopharmaceuticals, vaccines and other biotechnology products. The primary purpose of bioprocess automation is to enhance process efficiency, consistency and product quality while reducing human error and operational costs.
The global bioprocess automation market reached a value of nearly $5,672.39 million in 2024, having grown at a compound annual growth rate (CAGR) of 13.37% since 2019. The market is expected to grow from $5,672.39 million in 2024 to $10,237.74 million in 2029 at a rate of 12.53%. The market is then expected to grow at a CAGR of 12.02% from 2029 and reach $18,059.34 million in 2034.
Growing Demand For Personalized Medicine
During the historic period, the bioprocess automation market was mainly driven by the growing demand for personalized medicine. This demand created a strong push for automation technologies that can support rapid changeovers, precise process control and scalability in smaller production runs. Automation platforms enabled manufacturers to reduce variability and ensure consistency across highly specialized therapies, laying the foundation for wider adoption of bioprocess automation. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved a record 20 new personalized medicines, representing 38% of all new therapeutic molecular entities and marking the fourth consecutive year that personalized treatments accounted for more than a third of new drug approvals. This surge was especially significant in the rare disease category, with 16 personalized medicines approved for these conditions, more than doubling from just six approvals in 2022 and reflecting a major leap in addressing previously unmet medical needs in rare and often life-threatening genetic disorders. Therefore, the bioprocess automation market was mainly driven by the growing demand for personalized medicine.
Increasing Integration Of Artificial Intelligence And Machine Learning In Bioprocess Control
Companies operating in the bioprocess automation market are focusing on integrating artificial intelligence (AI) and machine learning (ML) into bioprocess control systems to enable predictive modelling, real-time decision-making and adaptive feedback control of upstream and downstream operations. These innovations are designed to improve yield consistency, reduce batch failures, minimize manual interventions and accelerate time-to-market while maintaining regulatory compliance and product quality. For instance, in July 2025, CPI (The Centre for Process Innovation), a UK-based technology and innovation center, joined the Canada-UK collaboration BALANCE (Bioreactor Automation for Learning and Adaptive Networked Control of Experiments), which combines real-time sensing via Nicoya, automation via Labman, AI (artificial intelligence) and digital twins via Basetwo and bioreactor technologies via CPI to deliver a demonstrator platform for AI-optimized bioreactor control for biologics manufacturing. Nicoya is a Canadian company specializing in biosensors, notably the Alto SPR biosensor. Labman Automation is a UK-based developer of automation and robotics; and Basetwo is a Canadian technology company focused on artificial intelligence and digital twin platforms.
The global bioprocess automation market is fairly fragmented, with a large number of small players operating in the market. The top ten competitors in the market made up to 19.55% of the total market in 2024.
Bioprocess Automation Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global bioprocess automation market as it emerges from the COVID-19 shut down.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for bioprocess automation? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The bioprocess automation market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider bioprocess automation market; and compares it with other markets.
The report covers the following chapters
Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by component of process control system, by scale of operation, mode of operation and by compatibility with bioprocessing systems.
Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
Global Market Size And Growth - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods
Regional And Country Analysis - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by component of process control system, by scale of operation, mode of operation and by compatibility with bioprocessing systems in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for bioprocess automation market providers in terms of product/service offerings geographic expansion, marketing strategies and target groups next five years.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
1) By Component Of Process Control System: Sensors; Actuators; Controllers
2) By Scale Of Operation: Preclinical Operations; Clinical Operations; Commercial Operations
3) By Mode Of Operation: Batch; Fed-Batch; Perfusion
4) By Compatibility With Bioprocessing Systems: Single-Use Systems; Stainless Steel; Other Bioprocessing Systems
8.7 Global Bioprocess Automation Total Addressable Market (TAM)
9 Global Bioprocess Automation Market Segmentation
9.1 Global Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.2 Global Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.3 Global Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.4 Global Bioprocess Automation Market, Segmentation By Compatibility With Bioprocessing Systems, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.5 Global Bioprocess Automation Market, Sub-Segmentation Of Sens0rs, By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.6 Global Bioprocess Automation Market, Sub-Segmentation Of Actuators, By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.7 Global Bioprocess Automation Market, Sub-Segmentation Of Controllers, By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10 Bioprocess Automation Market, Regional and Country Analysis
10.1 Global Bioprocess Automation Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.2 Global Bioprocess Automation Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11 Asia-Pacific Market
11.1 Summary
11.2 Market Overview
11.2.1 Region Information
11.2.2 Market Information
11.2.3 Background Information
11.2.4 Government Initiatives
11.2.5 Regulations
11.2.6 Regulatory Bodies
11.2.7 Major Associations
11.2.8 Taxes Levied
11.2.9 Corporate Tax Structure
11.2.10 Investments
11.2.11 Major Companies
11.3 Asia-Pacific Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.4 Asia-Pacific Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.5 Asia-Pacific Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.6 Asia-Pacific Bioprocess Automation Market: Country Analysis
11.7 China Market
11.8 Summary
11.9 Market Overview
11.9.1 Country Information
11.9.2 Market Information
11.9.3 Background Information
11.9.4 Government Initiatives
11.9.5 Regulations
11.9.6 Regulatory Bodies
11.9.7 Major Associations
11.9.8 Taxes Levied
11.9.9 Corporate Tax Structure
11.9.10 Investments
11.9.11 Major Companies
11.10 China Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.11 China Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.12 China Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.13 India Market
11.14 India Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.15 India Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.16 India Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.17 Japan Market
11.18 Summary
11.19 Market Overview
11.19.1 Country Information
11.19.2 Market Information
11.19.3 Background Information
11.19.4 Government Initiatives
11.19.5 Regulations
11.19.6 Regulatory Bodies
11.19.7 Major Associations
11.19.8 Taxes Levied
11.19.9 Corporate Tax Structure
11.19.10 Investments
11.19.11 Major Companies
11.20 Japan Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.21 Japan Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.22 Japan Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.23 Australia Market
11.24 Australia Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.25 Australia Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.26 Australia Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.27 Indonesia Market
11.28 Indonesia Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.29 Indonesia Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.30 Indonesia Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.31 South Korea Market
11.32 Summary
11.33 Market Overview
11.33.1 Country Information
11.33.2 Market Information
11.33.3 Background Information
11.33.4 Government Initiatives
11.33.5 Regulations
11.33.6 Regulatory Bodies
11.33.7 Major Associations
11.33.8 Taxes Levied
11.33.9 Corporate Tax Structure
11.33.10 Investments
11.33.11 Major Companies
11.34 South Korea Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.35 South Korea Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.36 South Korea Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12 Western Europe Market
12.1 Summary
12.2 Market Overview
12.2.1 Region Information
12.2.2 Market Information
12.2.3 Background Information
12.2.4 Government Initiatives
12.2.5 Regulations
12.2.6 Regulatory Bodies
12.2.7 Major Associations
12.2.8 Taxes Levied
12.2.9 Corporate tax structure
12.2.10 Investments
12.2.11 Major Companies
12.3 Western Europe Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.4 Western Europe Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.5 Western Europe Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.6 UK Market
12.7 UK Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.8 UK Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.9 UK Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.10 Germany Market
12.11 Germany Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.12 Germany Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.13 Germany Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.14 France Market
12.15 France Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.16 France Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.17 France Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.18 Italy Market
12.19 Italy Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.20 Italy Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.21 Italy Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.22 Spain Market
12.23 Spain Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.24 Spain Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.25 Spain Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13 Eastern Europe Market
13.1 Summary
13.2 Market Overview
13.2.1 Region Information
13.2.2 Market Information
13.2.3 Background Information
13.2.4 Government Initiatives
13.2.5 Regulations
13.2.6 Regulatory Bodies
13.2.7 Major Associations
13.2.8 Taxes Levied
13.2.9 Corporate Tax Structure
13.2.10 Investments
13.2.11 Major companies
13.3 Eastern Europe Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.4 Eastern Europe Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.5 Eastern Europe Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.6 Eastern Europe Bioprocess Automation Market: Country Analysis
13.7 Russia Market
13.8 Russia Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.9 Russia Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.10 Russia Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14 North America Market
14.1 Summary
14.2 Market Overview
14.2.1 Region Information
14.2.2 Market Information
14.2.3 Background Information
14.2.4 Government Initiatives
14.2.5 Regulations
14.2.6 Regulatory Bodies
14.2.7 Major Associations
14.2.8 Taxes Levied
14.2.9 Corporate Tax Structure
14.2.10 Investments
14.2.11 Major Companies
14.3 North America Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.4 North America Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.5 North America Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.6 North America Bioprocess Automation Market: Country Analysis
14.7 USA Market
14.8 Summary
14.9 Market Overview
14.9.1 Country Information
14.9.2 Market Information
14.9.3 Background Information
14.9.4 Government Initiatives
14.9.5 Regulations
14.9.6 Regulatory Bodies
14.9.7 Major Associations
14.9.8 Taxes Levied
14.9.9 Corporate Tax Structure
14.9.10 Investments
14.9.11 Major Companies
14.10 USA Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.11 USA Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.12 USA Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.13 Canada Market
14.14 Summary
14.15 Market Overview
14.15.1 Country Information
14.15.2 Market Information
14.15.3 Background Information
14.15.4 Government Initiatives
14.15.5 Regulations
14.15.6 Regulatory Bodies
14.15.7 Major Associations
14.15.8 Taxes Levied
14.15.9 Corporate Tax Structure
14.15.10 Investments
14.15.11 Major Companies
14.16 Canada Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.17 Canada Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.18 Canada Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15 South America Market
15.1 Summary
15.2 Market Overview
15.2.1 Region Information
15.2.2 Market Information
15.2.3 Background Information
15.2.4 Government Initiatives
15.2.5 Regulations
15.2.6 Regulatory Bodies
15.2.7 Major Associations
15.2.8 Taxes Levied
15.2.9 Corporate Tax Structure
15.2.10 Major Companies
15.3 South America Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.4 South America Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.5 South America Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.6 South America Bioprocess Automation Market: Country Analysis
15.7 Brazil Market
15.8 Brazil Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.9 Brazil Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.10 Brazil Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16 Middle East Market
16.1 Summary
16.2 Market Overview
16.2.1 Region Information
16.2.2 Market Information
16.2.3 Background Information
16.2.4 Government Initiatives
16.2.5 Regulations
16.2.6 Regulatory Bodies
16.2.7 Major Associations
16.2.8 Taxes Levied
16.2.9 Corporate Tax Structure
16.2.10 Investments
16.2.11 Major Companies
16.3 Middle East Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.4 Middle East Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.5 Middle East Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17 Africa Market
17.1 Summary
17.2 Market Overview
17.2.1 Region Information
17.2.2 Market Information
17.2.3 Background Information
17.2.4 Government Initiatives
17.2.5 Regulations
17.2.6 Regulatory Bodies
17.2.7 Major Associations
17.2.8 Taxes Levied
17.2.9 Corporate Tax Structure
17.2.10 Major Companies
17.3 Africa Bioprocess Automation Market, Segmentation By Component Of Process Control System, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.4 Africa Bioprocess Automation Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.5 Africa Bioprocess Automation Market, Segmentation By Mode Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
